PRGO
Perrigo Company plc · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers):
breedte van houders -13.3% ·
aandelenstroom +25.1% ·
netto nieuwe posities -15.4%
— formule
Geconcentreerde accumulatie — stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | +2 | 113.09M | $1.17B | +10 | −7 |
| Q1 2026 | 101 | +4 | 101.94M | $1.09B | +11 | −8 |
| Q4 2025 | 98 | -2 | 106.62M | $1.48B | +3 | −4 |
| Q3 2025 | 19 | 0 | 63.63M | $1.42B | +1 | −2 |
| Q2 2025 | 17 | 0 | 58.29M | $1.56B | — | — |
| Q1 2025 | 14 | +1 | 29.73M | $833.59M | +1 | — |
| Q4 2024 | 13 | -2 | 24.99M | $642.39M | — | −2 |
| Q3 2024 | 14 | -1 | 13.07M | $342.69M | — | −1 |
| Q2 2024 | 15 | — | 10.85M | $278.70M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 7.85M | +6828.9% | $201.71M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 7.85M | +6828.9% | $201.71M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passief) | 6.90M | — | $177.35M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.69M | -0.1% | $69.27M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.69M | -0.1% | $69.27M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.69M | -0.1% | $69.27M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passief) | 2.34M | -0.6% | $60.28M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passief) | 2.34M | -0.6% | $60.28M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 1.90M | -39.6% | $48.96M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 1.90M | -39.6% | $48.96M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Norges Bank ✦ (passief) | 1.42M | +1.4% | $36.61M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | GAMCO Investors ✦ | 742.82K | -3.8% | $19.10M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 546.70K | -28.1% | $14.06M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 197.13K | -72.6% | $5.01M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 197.13K | -72.6% | $5.01M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 197.13K | -72.6% | $5.01M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Marshall Wace ✦ | 166.86K | +500.6% | $4.29M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Marshall Wace ✦ | 166.86K | +500.6% | $4.29M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 112.58K | +17.9% | $2.89M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Arrowstreet Capital ✦ | 72.24K | -74.0% | $1.86M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Millennium Management ✦ | 38.74K | -93.7% | $996,083 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| D. E. Shaw & Co. | $1.45M | was 0.0% |
| Bridgewater Associates | $557,860 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 326 houders, 151.12M aandelen, $1.41B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.